Method and kit for detection of autoimmune chronic urticaria
View Patent ↗Disclosed is a rapid, non-invasive and highly specific and sensitive diagnostic assay for the identification of individuals with autoimmune chronic urticaria, which makes use of CD203c, and in some embodiments, additional proteins, as a marker for the disease. Test kits for diagnosis of an individual suspected of having autoimmune chronic urticaria are also disclosed. Also disclosed are a method of identifying compounds useful for treating autoimmune chronic urticaria and a method of treating autoimmune chronic urticaria.
1. A kit for the diagnosis of autoimmune chronic urticaria, comprising:
a) isolated donor cells that are selected for expressing CD203c and FcεRI and that upregulate the expression of CD203c upon stimulation of FcεRI, wherein the selected cells are present in a whole blood sample from a donor or are present in peripheral blood cells from a donor;
b) a CD203c reagent that specifically binds to CD203c and detects for CD203c expression from the cells; and
c) wherein the kit does not comprise interleukin-3 (IL-3).
2. The kit of claim 1 , wherein the reagent that specifically binds to CD203c for detection of CD203c expression on the cells is a CD203c antibody or antigen-binding fragment thereof.
3. The kit of claim 2 further comprising a second labeled antibody that binds to CD203c for the detection of CD203c: antibody complexes.
4. The kit of claim 1 , wherein the antibody is a monoclonal antibody.
5. The kit of claim 1 , further comprising a reagent selected from the group consisting of a positive control reagent and a negative control reagent.
6. The kit of claim 5 , wherein the positive control reagent is selected from the group consisting of formyl-methionyl-leucyl-phenylalanine (fMLP) and anti-FcεRIα.
7. The kit of claim 5 , wherein the negative control reagent comprises a buffer and a known negative serum.
8. The kit of claim 7 , wherein the known negative serum is from an individual that does not have chronic urticaria.
9. The kit of claim 1 , wherein the cells are basophils.
10. The kit of claim 1 , wherein the cells are provided as a whole blood sample.
11. The kit of claim 1 , wherein the reagent for detection of CD203c expression on the cells is a probe or primer.
12. The kit of claim 11 , wherein the probe or primer binds to CD203c.
13. The kit of claim 11 , wherein the probe or primer binds to a gene encoding CD203c.
14. The kit of claim 11 , wherein the probe or primer may be present in free form or immobilized to a substrate selected from the group consisting of a plastic dish, a test tube, and a test rod.